Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

M. Gentile; G. Specchia; D. Derudas; M. Galli; C. Botta; S. Rocco; C. Conticello; C. Califano; N. Giuliani; S. Mangiacavalli; E. Attingenti; A. Lombardo; M. Brunori; E. Rossi; E. Antonioli; R. Ria; R. Zambello; N. Di Renzo; G. Mele; G. Marcacci; P. Musto; S. Capalbo; N. Cascavilla; C. Cerchione; A. Belotti; C. Criscuolo; G. Uccello; P. Curci; E. Vigna; V. Fraticelli; D. Vincelli; A. Bonalumi; A. Siniscalchi; R. Stocchi; M. Martino; S. Ballanti; D. Gangemi; A. Gagliardi; B. Gamberi; A. Pompa; A.G. Recchia; G. Tripepi; A. Pitino; F. Frigeri; U. Consoli; S. Bringhen; E. Zamagni; F. Patriarca; V. De Stefano; F. Di Raimondo; S. Palmieri; M.T. Petrucci; M. Offidani; M. Boccadoro; M. Cavo; F. Morabito

doi:10.3324/haematol.2019.241513

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

M. Gentile, G. Specchia, D. Derudas, M. Galli, C. Botta, S. Rocco, C. Conticello, C. Califano, N. Giuliani, S. Mangiacavalli, E. Attingenti, A. Lombardo, M. Brunori, E. Rossi, E. Antonioli, R. Ria, R. Zambello, N. Di Renzo, G. Mele, G. MarcacciP. Musto, S. Capalbo, N. Cascavilla, C. Cerchione, A. Belotti, C. Criscuolo, G. Uccello, P. Curci, E. Vigna, V. Fraticelli, D. Vincelli, A. Bonalumi, A. Siniscalchi, R. Stocchi, M. Martino, S. Ballanti, D. Gangemi, A. Gagliardi, B. Gamberi, A. Pompa, A.G. Recchia, G. Tripepi, A. Pitino, F. Frigeri, U. Consoli, S. Bringhen, E. Zamagni, F. Patriarca, V. De Stefano, F. Di Raimondo, S. Palmieri, M.T. Petrucci, M. Offidani, M. Boccadoro, M. Cavo, F. Morabito

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	291-294
Number of pages	4
Journal	Haematologica
Volume	106
Issue number	1
DOIs	https://doi.org/10.3324/haematol.2019.241513
Publication status	Published - 2021

Access to Document

10.3324/haematol.2019.241513

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099006875&doi=10.3324%2fhaematol.2019.241513&partnerID=40&md5=38f8ccda2421003cb206d1ddbad71c97

Cite this

Gentile, M., Specchia, G., Derudas, D., Galli, M., Botta, C., Rocco, S., Conticello, C., Califano, C., Giuliani, N., Mangiacavalli, S., Attingenti, E., Lombardo, A., Brunori, M., Rossi, E., Antonioli, E., Ria, R., Zambello, R., Di Renzo, N., Mele, G., ... Morabito, F. (2021). Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials. Haematologica, 106(1), 291-294. https://doi.org/10.3324/haematol.2019.241513

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials. / Gentile, M.; Specchia, G.; Derudas, D. et al.

In: Haematologica, Vol. 106, No. 1, 2021, p. 291-294.

Research output: Contribution to journal › Article › peer-review

Gentile, M, Specchia, G, Derudas, D, Galli, M, Botta, C, Rocco, S, Conticello, C, Califano, C, Giuliani, N, Mangiacavalli, S, Attingenti, E, Lombardo, A , Brunori, M , Rossi, E, Antonioli, E, Ria, R, Zambello, R, Di Renzo, N, Mele, G , Marcacci, G, Musto, P, Capalbo, S, Cascavilla, N , Cerchione, C, Belotti, A, Criscuolo, C, Uccello, G, Curci, P, Vigna, E, Fraticelli, V, Vincelli, D, Bonalumi, A, Siniscalchi, A, Stocchi, R, Martino, M, Ballanti, S, Gangemi, D, Gagliardi, A , Gamberi, B, Pompa, A, Recchia, AG, Tripepi, G, Pitino, A, Frigeri, F, Consoli, U, Bringhen, S, Zamagni, E, Patriarca, F, De Stefano, V, Di Raimondo, F, Palmieri, S, Petrucci, MT, Offidani, M, Boccadoro, M, Cavo, M & Morabito, F 2021, 'Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials', Haematologica, vol. 106, no. 1, pp. 291-294. https://doi.org/10.3324/haematol.2019.241513

@article{2b5f8669bbf84661b41141e6ffe9b629,

title = "Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials",

author = "M. Gentile and G. Specchia and D. Derudas and M. Galli and C. Botta and S. Rocco and C. Conticello and C. Califano and N. Giuliani and S. Mangiacavalli and E. Attingenti and A. Lombardo and M. Brunori and E. Rossi and E. Antonioli and R. Ria and R. Zambello and {Di Renzo}, N. and G. Mele and G. Marcacci and P. Musto and S. Capalbo and N. Cascavilla and C. Cerchione and A. Belotti and C. Criscuolo and G. Uccello and P. Curci and E. Vigna and V. Fraticelli and D. Vincelli and A. Bonalumi and A. Siniscalchi and R. Stocchi and M. Martino and S. Ballanti and D. Gangemi and A. Gagliardi and B. Gamberi and A. Pompa and A.G. Recchia and G. Tripepi and A. Pitino and F. Frigeri and U. Consoli and S. Bringhen and E. Zamagni and F. Patriarca and {De Stefano}, V. and {Di Raimondo}, F. and S. Palmieri and M.T. Petrucci and M. Offidani and M. Boccadoro and M. Cavo and F. Morabito",

note = "Cited By :1 Export Date: 27 January 2021",

year = "2021",

doi = "10.3324/haematol.2019.241513",

language = "English",

volume = "106",

pages = "291--294",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "1",

}

TY - JOUR

T1 - Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

AU - Gentile, M.

AU - Specchia, G.

AU - Derudas, D.

AU - Galli, M.

AU - Botta, C.

AU - Rocco, S.

AU - Conticello, C.

AU - Califano, C.

AU - Giuliani, N.

AU - Mangiacavalli, S.

AU - Attingenti, E.

AU - Lombardo, A.

AU - Brunori, M.

AU - Rossi, E.

AU - Antonioli, E.

AU - Ria, R.

AU - Zambello, R.

AU - Di Renzo, N.

AU - Mele, G.

AU - Marcacci, G.

AU - Musto, P.

AU - Capalbo, S.

AU - Cascavilla, N.

AU - Cerchione, C.

AU - Belotti, A.

AU - Criscuolo, C.

AU - Uccello, G.

AU - Curci, P.

AU - Vigna, E.

AU - Fraticelli, V.

AU - Vincelli, D.

AU - Bonalumi, A.

AU - Siniscalchi, A.

AU - Stocchi, R.

AU - Martino, M.

AU - Ballanti, S.

AU - Gangemi, D.

AU - Gagliardi, A.

AU - Gamberi, B.

AU - Pompa, A.

AU - Recchia, A.G.

AU - Tripepi, G.

AU - Pitino, A.

AU - Frigeri, F.

AU - Consoli, U.

AU - Bringhen, S.

AU - Zamagni, E.

AU - Patriarca, F.

AU - De Stefano, V.

AU - Di Raimondo, F.

AU - Palmieri, S.

AU - Petrucci, M.T.

AU - Offidani, M.

AU - Boccadoro, M.

AU - Cavo, M.

AU - Morabito, F.

N1 - Cited By :1 Export Date: 27 January 2021

PY - 2021

Y1 - 2021

U2 - 10.3324/haematol.2019.241513

DO - 10.3324/haematol.2019.241513

M3 - Article

VL - 106

SP - 291

EP - 294

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 1

ER -